Association Between Preexisting ILAs, Smoking History and ICI-Related Pneumonitis
Researchers investigated the association between preexisting interstitial lung abnormalities and immune checkpoint inhibitor-related pneumonitis.
Diagnosis & Disease Information
Lymphovascular Invasion Ups Mortality Risk in Kidney Cancer Surgery Cases
Investigators believe their study is the first to demonstrate the adverse impact of LVI on overall survival in patients with surgically treated renal cell carcinoma.
Younger Kidney Cancer Patients on VEGF Inhibitors at Elevated Risk for Hypertension
Vascular endothelial growth factor inhibitors tied to hypertension among people aged 18 to 39 years being treated for renal cancer.
Imaging Technique Shows Promise in Determining RCC Treatment Response, Prognosis
This review of computed tomography texture analysis shows its potential for monitoring treatment responses and tumor evolution over time, particularly in renal cell carcinoma.
Lung Cancer Patients Hospitalized With irAEs Due to ICIs Have Shorter Survival
Lung cancer patients treated with immune checkpoint inhibitors experience worse immune-related adverse event survival than other cancer patients.
Clinical Pathway Regimens Cut Costs for Patients With Metastatic Solid Tumors
Clinical pathway treatment regimens are associated with significant cost savings for patients with metastatic solid tumors, a study suggests.
Groundwater Constituents May Increase the Risk of Kidney Cancer
An analysis of groundwater revealed 7 constituents — such as chlordane, dieldrin, and glyphosphate — that may increase the risk of kidney cancer.
Anti-PD-L1 Combinations Produce Mixed Results in Metastatic RCC
Anti-PD-L1-based therapies may improve some outcomes over sunitinib in patients with metastatic renal cell carcinoma, a meta-analysis suggests.
Early Death May Be Common in Cancer Patients Taking Immune Checkpoint Inhibitors
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Blood Type Associated With Immunotherapy Outcomes in RCC
Blood type may impact immunotherapy outcomes in patients with metastatic RCC, a study suggests.
- Loading...
Loading...
Next post in Kidney Cancer
Loading... 
Loading...